Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Shiatsu Adjuvant Therapy And Placebo For Schizophrenia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2009 by Herzog Hospital.
Recruitment status was:  Not yet recruiting
Information provided by:
Herzog Hospital Identifier:
First received: November 10, 2008
Last updated: January 12, 2009
Last verified: January 2009
In the current study we will study the effect of adding acupressure (shiatsu) to conventional therapy in treating individuals with schizophrenia.

Condition Intervention
Behavioral: Acupressure adjuvant therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Shiatsu Adjuvant Therapy And Placebo For Schizophrenia:a Double Blind Study

Resource links provided by NLM:

Further study details as provided by Herzog Hospital:

Primary Outcome Measures:
  • Brief Psychiatric Rating Scale (BPRS) [ Time Frame: 16 weeks ]

Estimated Enrollment: 150
Study Start Date: January 2009
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Acupressure
Acupressure adjuvant therapy
Behavioral: Acupressure adjuvant therapy
Acupressure provided in 40-minute sessions, twice a week for 4 weeks. For placebo acupressure, different meridian points will be used.
Other Name: Shiatsu
Placebo Comparator: Placebo acupressure
Sham acupressure adjuvant therapy
Behavioral: Acupressure adjuvant therapy
Acupressure provided in 40-minute sessions, twice a week for 4 weeks. For placebo acupressure, different meridian points will be used.
Other Name: Shiatsu
No Intervention: No treatment
Wait list group (no treatment)

Detailed Description:

Acupressure, also known as shiatsu, is a holistic form of medicine originating in Japan but now widely practiced throughout the world. The theory is based on Traditional Chinese Medicine (TCM), which sees meridians of life force (chi) running through the body, and aims to optimize health through manipulating the body into maximal alignment.

We are proposing a randomized double-blind placebo-controlled trial to examine the efficacy of acupressure as adjuvant therapy added to antipsychotics in the treatment of patients with schizophrenia.

The goals of this study are twofold:

  1. To assess through the highest standards of empirical research whether acupressure can benefit patients with schizophrenia.
  2. To furnish data relevant to the possible physiological mechanisms by which acupressure may produce a therapeutic effect.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. DSM-IV diagnosis of schizophrenia or schizoaffective disorder
  2. Ages 18 and over
  3. Clinical status stable, as reflected by changes in Brief Psychiatric Rating Scale (BPRS) (Overall & Gorham, 1961) of less than 20% during a one month period prior to randomization, and at least one month of drug treatment without change of anti-psychotic drug or dosage.
  4. Ability to cooperate with 40-minute sessions

Exclusion Criteria:

  1. Unstable general medical conditions
  2. Active bone fracture or other orthopedic problem
  3. Skin condition that renders treatment unsafe or painful
  4. Active infection in skin or soft tissues, such as cellulitis
  5. Solid tissue malignancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00788970

Contact: Pesach Lichtenberg 972-2-5316929

Herzog Hospital, Department of Psychiatry
Jerusalem, Israel, 91351
Sponsors and Collaborators
Herzog Hospital
Principal Investigator: Pesach Lichtenberg, M.D. Herzog Hospital
  More Information

Responsible Party: Dr. Pesach Lichtenberg, Herzog Hospital Identifier: NCT00788970     History of Changes
Other Study ID Numbers: lichtenberg3
Study First Received: November 10, 2008
Last Updated: January 12, 2009

Keywords provided by Herzog Hospital:

Additional relevant MeSH terms:
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders processed this record on April 28, 2017